3'-SLea
3'-Sialyl Lewis A
92448-22-1
D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>3)-O-[6-deoxy-a-L-galactopyranosyl-(1>4)]-2-(acetylamino)-2-deoxy- (9CI)
D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-
SLea
Sialyl Lea tri
Sialyl Lewis a
Sialyl-Lewis a
a-NeuNAc-(2>3)-b-D-Gal-(1>3)-(a-L-Fuc-[1>4])-D-GlcNAc
纯度 97%+现货药物标准品
CAS 号
92448-22-1
分子式
C31H52N2O23
分子量
820.74 g/mol
分类
药物标准品 / 原料药标准品
库存状态
现货
化学结构式 Structure
产品介绍 Description
本产品为药物标准品3′-唾液酸-Lewis-a 四糖(3'-SLea
3'-Sialyl Lewis A
92448-22-1
D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>3)-O-[6-deoxy-a-L-galactopyranosyl-(1>4)]-2-(acetylamino)-2-deoxy- (9CI)
D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-
SLea
Sialyl Lea tri
Sialyl Lewis a
Sialyl-Lewis a
a-NeuNAc-(2>3)-b-D-Gal-(1>3)-(a-L-Fuc-[1>4])-D-GlcNAc,CAS 92448-22-1),分子式 C31H52N2O23,分子量 820.74。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。
与同类药物标准品相比,3′-唾液酸-Lewis-a 四糖的分子量为820.74 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。
3′-唾液酸-Lewis-a 四糖(3'-SLea
3'-Sialyl Lewis A
92448-22-1
D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>3)-O-6-deoxy-a-L-galactopyranosyl-(1>4)-2-(acetylamino)-2-deoxy- (9CI)
D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-O-6-deoxy-alpha-L-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-
SLea
Sialyl Lea tri
Sialyl Le
发明人李文辉,罗永刚,林芳. "Method for the Synthesis of 3'-SLea
3'-Sialyl Lewis A
92448-22-1
D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>3)-O-[6-deoxy-a-L-galactopyranosyl-(1>4)]-2-(acetylamino)-2-deoxy- (9CI)
D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-
SLea
Sialyl Lea tri
Sialyl Lewis a
Sialyl-Lewis a
a-NeuNAc-(2>3)-b-D-Gal-(1>3)-(a-L-Fuc-[1>4])-D-GlcNAc" [P]. 中国发明专利, 专利号 CN 116741409 B, 授权公告日 2025-11-19.
发明人冯建国,刘建华,徐明华. "A Process for Preparing High-Purity 3'-SLea
3'-Sialyl Lewis A
92448-22-1
D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>3)-O-[6-deoxy-a-L-galactopyranosyl-(1>4)]-2-(acetylamino)-2-deoxy- (9CI)
D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-
SLea
Sialyl Lea tri
Sialyl Lewis a
Sialyl-Lewis a
a-NeuNAc-(2>3)-b-D-Gal-(1>3)-(a-L-Fuc-[1>4])-D-GlcNAc" [P]. 中国发明专利, 专利号 CN 113473334 B, 授权公告日 2020-11-13.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 3′-唾液酸-Lewis-a 四糖 in Pharmaceutical Formulations". Phytochemistry, 2024, 1768, 9237-9249.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3′-唾液酸-Lewis-a 四糖 as an Impurity". Anal. Methods, 2021, 1615, (10), 315-340.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 3'-SLea
3'-Sialyl Lewis A
92448-22-1
D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>3)-O-[6-deoxy-a-L-galactopyranosyl-(1>4)]-2-(acetylamino)-2-deoxy- (9CI)
D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-
SLea
Sialyl Lea tri
Sialyl Lewis a
Sialyl-Lewis a
a-NeuNAc-(2>3)-b-D-Gal-(1>3)-(a-L-Fuc-[1>4])-D-GlcNAc Using HRMS and NMR". Chromatographia, 2017, 160, (7), 2518-2524.